Strata Critical Medical, Inc. (SRTA) — Financial statements
Income statement, balance sheet, and cash flow for Strata Critical Medical, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 197↓20.7% | 249↑10.4% | 225↑54.1% | 146↑189.2% | 51 | |
| Cost of Revenue | 159↓16.3% | 190↑3.7% | 183↑47.8% | 124↑209.6% | 40 | |
| Gross Profit | 38↓35.0% | 59↑39.9% | 42↑89.1% | 22↑111.8% | 11 | |
| Operating Expenses | ||||||
| R&D Expenses | 3↓4.1% | 3↓31.2% | 5↓16.6% | 6↑229.3% | 2 | |
| General & Administrative Expenses | 0.00↓100.0% | 82↓14.1% | 95↑52.3% | 63↑107.4% | 30 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 8↓23.8% | 10↑34.7% | 8↑178.2% | 3 | |
| SG&A Expenses | 45↓49.7% | 90↓15.1% | 106↑50.3% | 70↑113.4% | 33 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 48↓48.2% | 93↓15.8% | 110↑45.4% | 76↑119.0% | 35 | |
| Total Costs & Expenses | 207↓26.8% | 283↓3.6% | 293↑46.9% | 200↑167.6% | 75 | |
| Operating Results | ||||||
| Operating Income | -10↑71.1% | -34↑50.2% | -68↓27.3% | -54↓122.2% | -24 | |
| Depreciation & Amortization | 7↑15.7% | 6↓16.2% | 7↑143.5% | -16↓2841.3% | 0.60 | |
| EBITDA | -3↑89.6% | -28↑54.2% | -61↑12.7% | -70↓197.3% | -23 | |
| EBIT | -10↑71.1% | -34↑50.2% | -68↓27.3% | -54↓122.2% | -24 | |
| Interest & Other Income | ||||||
| Net Interest Income | 4↓41.2% | 7↓14.5% | 8↑145.8% | 3↑646.5% | 0.46 | |
| Interest Income | 4↓41.2% | 7↓14.5% | 8↑145.8% | 3↑646.5% | 0.46 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | -10↓261.2% | 6↓39.8% | 11↓58.5% | 25↑230.1% | -20 | |
| Income Before Tax | -20↑27.2% | -28↑52.1% | -58↓105.3% | -28↑35.8% | -44 | |
| Income Tax Expense | 0.00↑100.0% | -0.26↑82.6% | -1↓89.9% | -0.77↑78.8% | -4 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -20↑26.5% | -27↑51.3% | -56↓105.7% | -27↑31.9% | -40 | |
| Net Income from Discontinued Operations | 4 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -16↑42.7% | -27↑51.3% | -56↓105.7% | -27↑31.9% | -40 | |
| Bottom-Line Net Income | -16↑42.7% | -27↑51.3% | -56↓105.7% | -27↑31.9% | -40 | |
| EPS (Basic) | -0.19↑45.7% | -0.35↑53.9% | -0.76↓100.0% | -0.38↑33.3% | -0.57 | |
| EPS (Diluted) | -0.19↑45.7% | -0.35↑53.9% | -0.76↓100.0% | -0.38↑33.3% | -0.57 | |
| Weighted Average Shares | 82↑6.4% | 77↑5.4% | 74↑3.2% | 71↑1.6% | 70 | |
| Weighted Average Diluted Shares | 82↑6.4% | 77↑5.4% | 74↑3.2% | 71↑1.6% | 70 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.